
Since the beginning of 1998 Hubert has been active in the biotech industry experiencing all the ups and downs for over ten years now. He was initiator and co-founder of both "Biochip Technologies GmbH" and "GeneScan Europe AG". There he held the position of the R&D manager/CSO. The company went public in July 2000 at the Frankfurt stock exchange. He is experienced in project management and has a broad spectrum of skills which qualifies him for heading start up and future emerging phases of biotech companies.
After first professional activities in the analytical biotech domain, he turned to synthetic biotechnology in 2001 starting with custom gene synthesis using his patented technology. This lead to him founding the synthetic biotechnology company "ATG:biosynthetics GmbH", Freiburg.
Synthetic Biology and analytical technologies are mutually intertwined. This analytical orientation was a valuable starting point for synthetic biology application developments in analytics and therapy. This valuable combination enables the development of individualized therapies.

Gregor Zipf, IT/ Programming: a trained physicist and one of our programming gurus